Hospitals & Clinics Segment by End User to Lead Concussion Market between 2021 and 2028

According to our new research study on "Concussion Market Forecast to 2028 - COVID-19 Impact and Analysis - by Type and End User," the market is expected to reach US$ 9,272.03 million by 2028 from US$ 7,211.89 million in 2021. It is estimated to grow at a CAGR of 3.7% from 2021 to 2028. The report highlights the key factors and trends impacting the market and focuses on prominent players and their strategies.

The American Psychological Association (APA) sanctioned protocols for computer-based testing and interpretation to distinguish promising advantages in a clinical setting. The primary advantage of computer-based testing for concussion involves greater access by the clinicians, compatibility with conventional testing forms, and cost-effectiveness. Progressive software programs such as CogSport, concussion resolution index (CRI), and immediate post-concussion assessment and cognitive testing (ImPact) offer valid, all-inclusive testing instruments for assessing cognitive symptoms associated with sports-related concussions.

The report of Frontiers S.A. states that concussion is a form of mild traumatic brain injury affecting thousands of Canadian children and adolescents annually. Timely access to primary and specialized care following the injury remains challenging, especially in rural and remote communities. Telemedicine has emerged as a significant tool in addressing disparities in healthcare accessibility for patients living in medically underserviced regions. This can be achieved with the proper establishment of novel telemedicine sites within established telemedicine networks; however, it can result in significant upfront costs for equipment, credentialing, and ongoing technical support and maintenance.

Based on the end user, the concussion market is segmented into hospitals & clinics, diagnostic centers, and others. The hospitals & clinics segment held the largest market share in 2021 and is anticipated to register the highest CAGR during the forecast period.

Nihon Koden Corporation; BrainScope Company, Inc.; Abbott, Compumedics Limited; InfraScan, Inc., Novasignal Corporation, Elekta AB, Integra Lifesciences, NanoDiagnostics, Inc., Medtronic are the leading companies operating in the concussion market.

The report segments the concussion market as follows:

The concussion market is assessed on the basis of type and end user. Based on the type, the market is segmented into treatment and diagnosis. The diagnosis market is further segmented into magnetic resonance imaging, computed tomography scan, x-rays, and others. Based on the end user, the concussion market is segmented into hospitals & clinics, diagnostic centers, and others.

By geography, the market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the rest of the Middle East & Africa), and South and Central America (Brazil, Argentina, and the rest of South and Central America).

Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@premiummarketinsights.com